Skip to main content
OpenTrials
Completed

NCT Number: NCT03487094

Growth and Tolerance of Infants Fed Formula for 16 Weeks

Growth and Tolerance Trial of Iron-fortified infant formulas

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Child Development

Age range

1 day–14 day

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Visions Clinical Research-Tucson, Tucson, Arizona, United States

Loading trial locations.

About this study

16 WEEK GROWTH AND TOLERANCE

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy term infants, 37-42 weeks gestational age

Exclusion criteria

  • Any condition that would negatively impact assessment of growth and tolerance

Treatment and study plan

Infant Formula

Other

Multi-centered, prospective, randomized clinical trial

Primary outcomes

  1. Growth

    Time frame: 16 weeks

    Weight Gain

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Nature's One

Industry

Registry information

Official study title

Growth Monitoring Study of Infants Fed Formula for 16 Weeks

Important dates

Study start
2018
Primary completion
2020
Study completion
2020
First posted
Apr 3, 2018
Registry last updated
Jul 10, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.